Integrated Insulin Pump and Continuous Glucose Monitoring Technology in Diabetes Care Today: A Perspective of Real-Life Experience With the Minimed™ 670G Hybrid Closed-Loop System
Authors:
- Grazia AleppoGAGrazia Aleppo
- Kimberly M. WebbKWKimberly M. Webb
- 1 July 2018
- journal article
- review article
- Published by Elsevier in Endocrine Practice
- Vol. 24 (7) , 684-692
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Future of the Artificial PancreasDiabetes Technology & Therapeutics, 2015
- Patient Behaviors Associated with Optimum Glycemic Outcomes with Sensor-Augmented Pump Therapy: Insights from The Star 3 StudyEndocrine Practice, 2015
- A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 DiabetesDiabetes Care, 2014
- Threshold-Based Insulin-Pump Interruption for Reduction of HypoglycemiaNew England Journal of Medicine, 2013
- Routine Sensor-Augmented Pump Therapy in Type 1 Diabetes: The INTERPRET StudyDiabetes Technology & Therapeutics, 2013
- Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 studyPediatric Diabetes, 2011
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesNew England Journal of Medicine, 2010
- Reduction to Normal of Plasma Glucose in Juvenile Diabetes by Subcutaneous Administration of Insulin with a Portable Infusion PumpNew England Journal of Medicine, 1979
- Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.BMJ, 1978
- Clinical Control of Diabetes by the Artificial PancreasDiabetes, 1974